Mackay Shields LLC’s Carter's CRI Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q2
Sell
-44,223
Closed -$3.93M 840
2021
Q1
$3.93M Buy
44,223
+12,792
+41% +$1.18M 0.03% 537
2020
Q4
$2.96M Buy
+31,431
New +$2.77M 0.02% 674
2019
Q2
Sell
-26,335
Closed -$2.65M 1416
2019
Q1
$2.65M Buy
+26,335
New +$2.35M 0.02% 626
2018
Q4
Sell
-93,898
Closed -$9.26M 1374
2018
Q3
$9.26M Sell
93,898
-26,315
-22% -$2.78M 0.07% 321
2018
Q2
$13M Sell
120,213
-91,527
-43% -$9.84M 0.09% 285
2018
Q1
$22M Buy
+211,740
New +$24.6M 0.14% 183

Other funds holding CRI

Mackay Shields LLC's CRI Position: Q2 2021 in Review

Mackay Shields LLC sold out of Carter's (CRI) in Q2 2021, closing a stake of 44,223 shares — an estimated $3.93M sold.

Mackay Shields LLC first reported a position in CRI in Q1 2018 and held it in 6 quarters. The position peaked at $22M in Q1 2018. 297 funds tracked by Wall St. Rank hold CRI as of Q2 2021.

  • Mackay Shields LLC reported no remaining Carter's position as of Q2 2021 after selling out during the quarter.
  • Mackay Shields LLC sold 44,223 Carter's shares in Q2 2021, an estimated $3.93M.
  • Mackay Shields LLC first reported a position in Carter's in Q1 2018 and held it in 6 quarters.
  • Mackay Shields LLC's Carter's position peaked at $22M in Q1 2018.
  • 297 funds tracked by Wall St. Rank held Carter's as of Q2 2021.

Based on Mackay Shields LLC's 13F filing for Q2 2021, filed 13 Aug 2021.